EA201792083A1 - ATTENUATED GRIPPOSOUS VECTORS FOR PREVENTION AND / OR TREATING INFECTIOUS DISEASES, AND ALSO FOR TREATING ONCOLOGICAL DISEASES - Google Patents
ATTENUATED GRIPPOSOUS VECTORS FOR PREVENTION AND / OR TREATING INFECTIOUS DISEASES, AND ALSO FOR TREATING ONCOLOGICAL DISEASESInfo
- Publication number
- EA201792083A1 EA201792083A1 EA201792083A EA201792083A EA201792083A1 EA 201792083 A1 EA201792083 A1 EA 201792083A1 EA 201792083 A EA201792083 A EA 201792083A EA 201792083 A EA201792083 A EA 201792083A EA 201792083 A1 EA201792083 A1 EA 201792083A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treating
- diseases
- attenuated
- prevention
- gripposous
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Настоящее изобретение относится к области медицины и вирусологии. Представлены аттенуированные вирусы гриппа А, гриппозные векторы на их основе и содержащие их фармацевтические композиции, которые могут применяться для профилактики и/или лечения инфекционных заболеваний. Дополнительно, настоящее изобретение относится к аттенуированным вирусам гриппа А, гриппозным векторам на их основе и содержащим их фармацевтическим композиция, которые могут применяться для лечения онкологических заболеваний.The present invention relates to the field of medicine and virology. Attenuated influenza A viruses, influenza vectors based on them, and pharmaceutical compositions containing them, which can be used for the prevention and / or treatment of infectious diseases, are presented. Additionally, the present invention relates to attenuated influenza A viruses, influenza vectors based on them, and a pharmaceutical composition containing them, which can be used to treat cancer diseases.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2015147703A RU2628690C2 (en) | 2015-11-06 | 2015-11-06 | Attenuated influenza vectors for the prevention and/or treatment of infectious diseases, as well as for cancer treatment |
RU2016111907A RU2660562C2 (en) | 2016-03-30 | 2016-03-30 | Attenuated grippose vector and mucosal universal grippose vaccine on its basis |
PCT/RU2016/050066 WO2017078577A2 (en) | 2015-11-06 | 2016-11-03 | Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201792083A1 true EA201792083A1 (en) | 2018-07-31 |
EA037571B1 EA037571B1 (en) | 2021-04-15 |
Family
ID=62748489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201792083A EA037571B1 (en) | 2015-11-06 | 2016-11-03 | Attenuated influenza a virus, attenuated influenza vector, pharmaceutical composition and use thereof in the prevention or treatment of infectious diseases and for the treatment of oncological diseases |
Country Status (3)
Country | Link |
---|---|
CL (1) | CL2018001201A1 (en) |
EA (1) | EA037571B1 (en) |
ZA (1) | ZA201803649B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1085904B1 (en) * | 1998-06-12 | 2012-11-28 | Mount Sinai School of Medicine | Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
WO2001064860A2 (en) * | 2000-03-02 | 2001-09-07 | Polymun Scientific Immunbiologische Forschung Gmbh | Recombinant influenza a viruses |
US7037707B2 (en) * | 2003-09-04 | 2006-05-02 | St. Jude Children's Research Hospital | Method for generating influenza viruses and vaccines |
-
2016
- 2016-11-03 EA EA201792083A patent/EA037571B1/en unknown
-
2018
- 2018-05-03 CL CL2018001201A patent/CL2018001201A1/en unknown
- 2018-05-31 ZA ZA201803649A patent/ZA201803649B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA037571B1 (en) | 2021-04-15 |
CL2018001201A1 (en) | 2018-09-21 |
ZA201803649B (en) | 2019-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201790700A1 (en) | MONO OR DESIGNED INDOLS AS AN INHIBITORS REPLICATION OF DENG VIRUSES | |
CY1121874T1 (en) | Mono- or Disubstituted Indole Derivatives as Dengue Virus Replication Inhibitors | |
ECSP17073878A (en) | DERIVED FROM INDOL MONO OR DISUSTITUTED AS INHIBITORS OF THE VIRAL REPLICATION OF DENGUE | |
EA201691261A1 (en) | NEW DIHYDROCHINOLYSINES FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY THE HEPATITIS B VIRUS | |
EA201691726A1 (en) | NEW 6-CONDENSED HETEROARYDYDYDROPYRIMIDIDES FOR THE TREATMENT AND PREVENTION OF HEPATITIS B VIRUS INFECTION | |
CY1122792T1 (en) | MONO-OR DISUBTITUTED INDOLE DERIVATIVES AS DANGE VIRUS REPLICATION INHIBITORS | |
EA201690306A1 (en) | IDO INHIBITORS | |
EA201690152A1 (en) | IDO INHIBITORS | |
EA201591599A1 (en) | IDO INHIBITORS | |
EA201791614A1 (en) | INDOL DERIVATIVES AS AN INHIBITORS OF DENGE VIRUS REPLICATION | |
EA201992784A1 (en) | SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS | |
EA201791916A1 (en) | 2'-SUBSTITUTED CARBANECULOSE ANALOGUES FOR ANTI-VIRUS TREATMENT | |
MX2022000453A (en) | Compounds useful to treat influenza virus infections. | |
MX2017015462A (en) | Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases. | |
EA201892216A1 (en) | SUBSTITUTED INDIN DERIVATIVES AS AN INHIBITORS OF DENG VIRUS REPLICATION | |
EA201992782A1 (en) | SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS | |
EA201890722A1 (en) | Derivatives of mono-or dislocated indo as an inhibitor of dengue virus replication | |
EA201590703A1 (en) | MEK INHIBITORS FOR TREATING VIRAL DISEASES | |
EA201692358A1 (en) | IZOINDOLIN DERIVATIVES FOR USE IN THE TREATMENT OF VIRAL INFECTION | |
MX2019004029A (en) | Compounds and methods for diagnosis and treatment of viral infections. | |
EA201990988A1 (en) | ANTIBODIES AGAINST CHIKV AND WAYS OF THEIR APPLICATION | |
EA201790776A1 (en) | COMBINED COMPOSITIONS OF LONG-TERM ACTIONS AND METHODS OF TREATING HEPATITIS C | |
EA201790771A1 (en) | PHARMACEUTICAL COMPOSITIONS OF LONG-TERM ACTION FOR THE TREATMENT OF HEPATITIS C | |
PH12017501943B1 (en) | Influenza virus neutralizing peptidomimetic compounds | |
EA201792083A1 (en) | ATTENUATED GRIPPOSOUS VECTORS FOR PREVENTION AND / OR TREATING INFECTIOUS DISEASES, AND ALSO FOR TREATING ONCOLOGICAL DISEASES |